Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adoport 1mg capsules
0802020T0BEAAAB
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 5,878 |
|
Adoport 0.5mg capsules
0802020T0BEACAF
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 3,375 |
|
Adoport 2mg capsules
0802020T0BEAEBG
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 2,032 |
|
Adoport 5mg capsules
0802020T0BEABAA
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 690 |
|
Adoport 0.75mg capsules
0802020T0BEADBF
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 395 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.